Autoimmune pancreatitis: an update

Ashish Khandelwal, Dai Inoue, Naoki Takahashi

Research output: Contribution to journalReview article

Abstract

Objective: Since the time of inception of autoimmune pancreatitis (AIP), our knowledge of autoimmune pancreatitis has expanded significantly. The aim of this review is to provide an update on clinical manifestations, diagnosis, imaging features, and treatment of AIP. Background and clinical significance: Type 1 AIP is the pancreatic manifestation of IgG4-related systemic disease, which can be diagnosed using a combination of clinical, histopathological, pancreatic imaging findings in conjunction with manifestation in other organs, as well of responsiveness to steroid treatment. It is vital to differentiate AIP from pancreatic cancer since both can mimic each other clinically and radiologically. Type 2 AIP is a rare but distinct subtype of AIP which occurs mostly in the younger patient. Conclusion: AIP is steroid-responsive chronic pancreatitis with distinct manifestations on imaging.

Original languageEnglish (US)
JournalAbdominal Radiology
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Pancreatitis
Steroids
Chronic Pancreatitis
Pancreatic Neoplasms
Immunoglobulin G
Therapeutics

Keywords

  • Autoimmune pancreatitis
  • Idiopathic duct-centric pancreatitis
  • IgG4
  • International consensus diagnostic criteria
  • Lymphoplasmacytic sclerosing pancreatitis

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging
  • Gastroenterology
  • Urology

Cite this

Autoimmune pancreatitis : an update. / Khandelwal, Ashish; Inoue, Dai; Takahashi, Naoki.

In: Abdominal Radiology, 01.01.2019.

Research output: Contribution to journalReview article

Khandelwal, Ashish ; Inoue, Dai ; Takahashi, Naoki. / Autoimmune pancreatitis : an update. In: Abdominal Radiology. 2019.
@article{cfc2a4edcc6740b28e96f78d12058a54,
title = "Autoimmune pancreatitis: an update",
abstract = "Objective: Since the time of inception of autoimmune pancreatitis (AIP), our knowledge of autoimmune pancreatitis has expanded significantly. The aim of this review is to provide an update on clinical manifestations, diagnosis, imaging features, and treatment of AIP. Background and clinical significance: Type 1 AIP is the pancreatic manifestation of IgG4-related systemic disease, which can be diagnosed using a combination of clinical, histopathological, pancreatic imaging findings in conjunction with manifestation in other organs, as well of responsiveness to steroid treatment. It is vital to differentiate AIP from pancreatic cancer since both can mimic each other clinically and radiologically. Type 2 AIP is a rare but distinct subtype of AIP which occurs mostly in the younger patient. Conclusion: AIP is steroid-responsive chronic pancreatitis with distinct manifestations on imaging.",
keywords = "Autoimmune pancreatitis, Idiopathic duct-centric pancreatitis, IgG4, International consensus diagnostic criteria, Lymphoplasmacytic sclerosing pancreatitis",
author = "Ashish Khandelwal and Dai Inoue and Naoki Takahashi",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00261-019-02275-x",
language = "English (US)",
journal = "Abdominal Radiology",
issn = "2366-004X",
publisher = "Springer New York",

}

TY - JOUR

T1 - Autoimmune pancreatitis

T2 - an update

AU - Khandelwal, Ashish

AU - Inoue, Dai

AU - Takahashi, Naoki

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: Since the time of inception of autoimmune pancreatitis (AIP), our knowledge of autoimmune pancreatitis has expanded significantly. The aim of this review is to provide an update on clinical manifestations, diagnosis, imaging features, and treatment of AIP. Background and clinical significance: Type 1 AIP is the pancreatic manifestation of IgG4-related systemic disease, which can be diagnosed using a combination of clinical, histopathological, pancreatic imaging findings in conjunction with manifestation in other organs, as well of responsiveness to steroid treatment. It is vital to differentiate AIP from pancreatic cancer since both can mimic each other clinically and radiologically. Type 2 AIP is a rare but distinct subtype of AIP which occurs mostly in the younger patient. Conclusion: AIP is steroid-responsive chronic pancreatitis with distinct manifestations on imaging.

AB - Objective: Since the time of inception of autoimmune pancreatitis (AIP), our knowledge of autoimmune pancreatitis has expanded significantly. The aim of this review is to provide an update on clinical manifestations, diagnosis, imaging features, and treatment of AIP. Background and clinical significance: Type 1 AIP is the pancreatic manifestation of IgG4-related systemic disease, which can be diagnosed using a combination of clinical, histopathological, pancreatic imaging findings in conjunction with manifestation in other organs, as well of responsiveness to steroid treatment. It is vital to differentiate AIP from pancreatic cancer since both can mimic each other clinically and radiologically. Type 2 AIP is a rare but distinct subtype of AIP which occurs mostly in the younger patient. Conclusion: AIP is steroid-responsive chronic pancreatitis with distinct manifestations on imaging.

KW - Autoimmune pancreatitis

KW - Idiopathic duct-centric pancreatitis

KW - IgG4

KW - International consensus diagnostic criteria

KW - Lymphoplasmacytic sclerosing pancreatitis

UR - http://www.scopus.com/inward/record.url?scp=85074580361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074580361&partnerID=8YFLogxK

U2 - 10.1007/s00261-019-02275-x

DO - 10.1007/s00261-019-02275-x

M3 - Review article

C2 - 31650376

AN - SCOPUS:85074580361

JO - Abdominal Radiology

JF - Abdominal Radiology

SN - 2366-004X

ER -